Effect of pyrazinamide resistance on treatment results of multidrug-resistant tuberculosis cases in Aegean region, Turkey Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008
Multidrug resistance tuberculosis (MDR-TB) in the north east area of Tunisia Source: Eur Respir J 2007; 30: Suppl. 51, 700s Year: 2007
Multi-drug resistance tuberculosis in Greece Source: Eur Respir J 2003; 22: Suppl. 45, 344s Year: 2003
Multidrug-resistant tuberculosis in the western region of Algeria Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
The Beijing genotype dominates the multidrug-resistant Mycobacterium tuberculosis population in North-West Russia Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021
Frequency of multi-drug resistant M.tuberculosis and HLA-class-2 gene associations in tuberculosis patients in the Republic of Tuva Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Mutations in the of rpoB gene in multidrug resistance mycobacterium tuberculosis from North Lima, Peru Source: Eur Respir J 2003; 22: Suppl. 45, 159s Year: 2003
Emergence of drug resistance in mycobacterium tuberculosis isolates in Ibadan, Nigeria Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007
Treatment outcome of multi-drug resistant tuberculosis in Varanasi, India Source: Eur Respir J 2002; 20: Suppl. 38, 615s Year: 2002
Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
XDR and MDR-TB genetic markers of M. tuberculosis strains circulating in Kyrgyz Republic Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011
Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009–2016 Source: Eur Respir J, 52 (1) 1800070; 10.1183/13993003.00070-2018 Year: 2018
Resistance of Mycobacterium tuberculosis to the first-line (MDR) and second line (XDR) anti tuberculosis drugs in the south western zone of Nigeria: A- 3 year retrospective study Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Resistance genotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Serbia Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Multi-drug resistant pulmonary tuberculosis in Belarus Source: Annual Congress 2007 - Epidemiology of various lung diseases Year: 2007
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia Source: Eur Respir J 2012; 40: 133-142 Year: 2012